GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synairgen PLC (OTCPK:SYGGF) » Definitions » Total Long-Term Liabilities

SYGGF (Synairgen) Total Long-Term Liabilities : $0.00 Mil (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Synairgen Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Synairgen's Total Long-Term Liabilities for the quarter that ended in Jun. 2024 was $0.00 Mil.

Synairgen Total Long-Term Liabilities Historical Data

The historical data trend for Synairgen's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synairgen Total Long-Term Liabilities Chart

Synairgen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 - - - -

Synairgen Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Synairgen Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Synairgen Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Synairgen's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Synairgen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synairgen PLC (OTCPK:SYGGF) » Definitions » Total Long-Term Liabilities
Comparable Companies
LSE:SAR LSE:POLB LSE:AREC LSE:IMM LSE:OPTI LSE:TRX LSE:OBD LSE:HEMO LSE:IXI LSE:APTA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
SNG:UK OMY:Germany
Address
Southampton General Hospital, Tremona Road, Mailpoint 810, Level F, South Block, Southampton, GBR, SO16 6YD
Website
https://www.synairgen.com
Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, SG018, and others.